Kenya AIDS Indicator Survey. 2007. Preliminary Report. Nairobi, Kenya: National AIDS and STI Control Programme, 2008.
2.
AluisioA, RichardsonBA, BosireR, John-StewartG, Mbori-NgachaD, FarquharC. Male antenatal attendance and HIV testing are associated with decreased infant HIV infection and increased HIV-free survival. J Acquir Immune Defic Syndr, 2010; 56:76–82.
3.
FarquharC, Mbori-NgachaDA, BosireRK, NduatiRW, KreissJK, JohnGC. Partner notification by HIV-1 seropositive pregnant women: Association with infant feeding decisions. AIDS, 2001; 15:815–817.
KuonzaLR, TshumaCD, ShambiraGN, TshimangaM. Non-adherence to the single dose nevirapine regimen for the prevention of mother-to-child transmission of HIV in Bindura town, Zimbabwe: A cross-sectional analytic study. BMC Public Health, 2010; 10:218.
6.
JasseronC, MandelbrotL, DollfusCet al.Non-Disclosure of a pregnant woman's HIV status to her partner is associated with non-optimal prevention of mother-to-child transmission. AIDS Behav 2011published online20111202.
7.
DuffP, KippW, WildTC, RubaaleT, Okech-OjonyJ. Barriers to accessing highly active antiretroviral therapy by HIV-positive women attending an antenatal clinic in a regional hospital in western Uganda. J Int AIDS Soc, 2010; 13:37.
8.
KirstenI, SewangiJ, KunzAet al.Adherence to combination prophylaxis for prevention of mother-to-child-transmission of HIV in Tanzania. PLoS One, 2011; 6:e21020.
9.
PeltzerK, MlamboG. Factors determining HIV viral testing of infants in the context of mother-to-child transmission. Acta Paediatr, 2010; 99:590–596.
10.
GuthrieBL, de BruynG, FarquharC. HIV-1-discordant couples in sub-Saharan Africa: Explanations and implications for high rates of discordancy. Curr HIV Res, 2007; 5:416–429.
11.
WereWA, MerminJH, WamaiNet al.Undiagnosed HIV infection and couple HIV discordance among household members of HIV-infected people receiving antiretroviral therapy in Uganda. J Acquir Immune Defic Syndr, 2006; 43:91–95.
12.
Desgrees-du-LouA, BrouH, TraoreAT, DjohanG, BecquetR, LeroyV. From prenatal HIV testing of the mother to prevention of sexual HIV transmission within the couple. Soc Sci Med, 2009; 69:892–899.
13.
MerminJ, LuleJ, EkwaruJPet al.Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet, 2004; 364:1428–1434.
14.
ObermeyerCM, BaijalP, PegurriE. Facilitating HIV disclosure across diverse settings: A review. Am J Public Health, 2011; 101:1011–1023.
15.
DillabaughLL, Lewis KulzerJ, OwuorKet al.Towards elimination of mother-to-child transmission of HIV: The impact of a rapid results initiative in Nyanza Province, Kenya. AIDS Res Treat, 2012; 2012:602120.
16.
AnglewiczP, ChintsanyaJ. Disclosure of HIV status between spouses in rural Malawi. AIDS Care, 2011; 23:998–1005.
17.
MakinJD, ForsythBW, VisserMJ, SikkemaKJ, NeufeldS, JefferyB. Factors affecting disclosure in South African HIV-positive pregnant women. AIDS Patient Care STDS, 2008; 22:907–916.
18.
SimbayiLC, KalichmanSC, StrebelA, CloeteA, HendaN, MqeketoA. Disclosure of HIV status to sex partners and sexual risk behaviours among HIV-positive men and women, Cape Town, South Africa. Sex Transm Infect, 2007; 83:29–34.
19.
DrakeAL, RoxbyAC, Ongecha-OwuorFet al.Valacyclovir suppressive therapy reduces plasma and breast milk HIV-1 RNA levels during pregnancy and postpartum: A randomized trial. J Infect Dis, 2012; 205:366–375.
20.
MuchetoP, ChadambukaA, ShambiraG, TshimangaM, GombeN, NyamayaroW. Determinants of nondisclosure of HIV status among women attending the prevention of mother to child transmission programme, Makonde district, Zimbabwe, 2009. Pan Afr Med J, 2011; 8:51.
21.
HardonA, VernooijE, Bongololo-MberaGet al.Women's views on consent, counseling and confidentiality in PMTCT: A mixed-methods study in four African countries. BMC Public Health, 2012; 12:26.
22.
OlagbujiBN, EzeanochieMC, AgholorKN, OlagbujiYW, AndeAB, OkonofuaFE. Spousal disclosure of HIV serostatus among women attending antenatal care in urban Nigeria. J Obstet Gynaecol, 2011; 31:486–488.
23.
MedleyA, Garcia-MorenoC, McGillS, MamanS. Rates, barriers and outcomes of HIV serostatus disclosure among women in developing countries: Implications for prevention of mother-to-child transmission programmes. Bull World Health Organ, 2004; 82:299–307.
24.
UNGASS Country Progress Report Rwanda January 2008–December 20092012 August 1http://data.unaids.org/pub/Report/2010/rwanda_2010_country_progress_report_en.pdf.
25.
KinuthiaJ, KiarieJN, FarquharCet al.Cofactors for HIV-1 incidence during pregnancy and postpartum period. Curr HIV Res, 2010; 8:510–514.
26.
MoodleyD, EsterhuizenT, ReddyLet al.Incident HIV infection in pregnant and lactating women and its effect on mother-to-child transmission in South Africa. J Infect Dis, 2011; 203:1231–1234.
